The further mechanistic study demonstrated that miR-365-3p was a negative regulator in IL17-mediated inflammation in both murine and human airway cells via miR-365-3p/ARRB2/cytokines axis, which may provide experimental evidence for the potential therapeutic targets of asthma. This evidence concerns the gene IL17A and asthma.